BARDAOvjeren akaunt

@BARDA

Biomedical Advanced Research and Development Authority (BARDA), a component of the HHS Assistant Secretary of Preparedness and Response (ASPR)

Washington, DC
Vrijeme pridruživanja: travanj 2017.

Tweetovi

Blokirali ste korisnika/cu @BARDA

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @BARDA

  1. prije 8 sati

    BARDA is soliciting simplified proposals under our streamlined, business friendly EZ-BAA for molecular diagnostics, based on -cleared/approved platforms. Find out how your company can partner with us!

    Poništi
  2. 4. velj

    We’re expanding our partnership w/ to use their existing monoclonal antibody discovery platform to develop multiple monoclonal antibodies that, individually or in combination, could be used to develop therapeutics to treat

    Poništi
  3. 3. velj

    Responding to an influenza pandemic requires more modern, domestically produced vaccines. We're excited to announce AUDENZ, a next-gen pandemic influenza vaccine using antigen-sparing adjuvant & cell-based vaccine technology, has been licensed by .

    Poništi
  4. proslijedio/la je Tweet
    30. sij

    BARDA is supporting US government market research to identify medical countermeasures with the potential to help address the outbreak. If your company is developing diagnostics, therapeutics, vaccines, or other products, submit your ideas here ➡️

    Poništi
  5. proslijedio/la je Tweet

    As part of the Administration’s work to protect Americans and respond to the 2019 Novel outbreak, today I signed a public health emergency declaration.

    Poništi
  6. 30. sij

    BARDA is supporting US government market research to identify medical countermeasures with the potential to help address the outbreak. If your company is developing diagnostics, therapeutics, vaccines, or other products, submit your ideas here ➡️

    Poništi
  7. proslijedio/la je Tweet
    29. sij

    Get the latest on issues surrounding the 2019 Novel . Register today to join us for a listening session to discuss medical countermeasures challenges and other public health and medical issues related to the current outbreak.

    Poništi
  8. 28. sij

    To help transform , new BARDA DRIVe partner Rizlab Health will leverage its pocket-sized blood count analyzer technology to develop a way to alert users of illness before symptoms occur. Learn more about and this project:

    Poništi
  9. 23. sij

    BARDA DRIVe is partnering with GE Research and Feinstein Institute for Medical Research to improve by leveraging portable ultrasound technology to test whether infection can be detected before symptoms occur. Learn more at

    Poništi
  10. proslijedio/la je Tweet

    Today, we celebrated the life of Edward J. Gabriel and honored him with the Investor in People Leadership Award. The contributions he made to New York City, to , and to the protection of his fellow Americans are a source of inspiration for all of us.

    Poništi
  11. proslijedio/la je Tweet
    13. sij

    Deadline approaching! The Invisible Shield seeks potential solutions that protect against airborne viruses & integrate into daily life. Apply for the chance to earn up to $200K in funding from + mentoring

    Poništi
  12. proslijedio/la je Tweet
    8. sij

    In cases where patients are infected with antibiotic resistant infections, a rapid diagnosis can save life or limb – and the need for speed skyrockets during a public health emergency. Find out what is doing to support fast, accurate diagnostics.

    Poništi
  13. 8. sij

    Every 11 seconds, someone in the U.S. is infected with drug-resistant bacteria, and current diagnostic tests don’t provide results quickly enough. Find out what BARDA is doing to bring diagnostics closer to the patient & rapidly diagnose infections.

    Poništi
  14. 23. pro 2019.

    When BARDA Director Rick Bright got a minor cut while gardening, he wasn’t expecting it to get infected with MRSA. Find out how that cut & a delayed diagnosis led to the misuse of antibiotics, threatened patient health, increased healthcare costs & more.

    Poništi
  15. 20. pro 2019.

    The has licensed ERVEBO, the world’s first vaccine to prevent disease. At BARDA, we are honored to be part of this unprecedented collaboration between & other key partners to develop this lifesaving vaccine.

    Poništi
  16. 18. pro 2019.

    BARDA is partnering with on the advanced development of an antibiotic to treat anthrax lung infections. NUZYRA is approved to treat community-acquired bacterial pneumonia & acute skin infections, which can complicate disaster response.

    Poništi
  17. 13. pro 2019.

    Erika Davies spoke at about our novel blood product and blood sustainability portfolio. BARDA works with partners to develop next generation blood products to after a event that could limit the US blood supply. RFI:

    Poništi
  18. 11. pro 2019.

    Director Bright is NYC for a discussion on protecting the world’s most populations. Disasters don't discriminate based on age, gender, socio-economics, or health status, so medical countermeasures must be available for all.

    Poništi
  19. proslijedio/la je Tweet

    As part of the administration's efforts , announced a new initiative to increase domestic capacity to manufacture recombinant flu vaccines, which are faster & more flexible than traditional egg-based approaches.

    Poništi
  20. 10. pro 2019.

    The DRIVe team at the 2019 Global Biosensors Summit sharing information on the Early Notification to Act, Control & Treat (ENACT) portfolio. Learn more about the ENACT program here:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·